Reconsidering treatment guidelines for acute myocardial infarction during the COVID-19 pandemic

Reconsidering treatment guidelines for acute myocardial infarction during the COVID-19 pandemic

Background: COVID-19 affects healthcare resource allocation, which could lead to treatment delay and poor outcomes in patients with acute myocardial infarction (AMI). We assessed the impact of the COVID-19 pandemic on AMI outcomes. Methods: We compared outcomes of patients admitted for acute ST-elev...

Full description

Bibliographic Details
Main Authors: Bai, M.-N (Author), Dou, J. (Author), Gao, J. (Author), Li, C.-P (Author), Li, X.-W (Author), Liu, Y. (Author), Lu, P.-J (Author), Shi, Y.-T (Author), Wang, H. (Author), Wang, J.-X (Author), Zan, C. (Author), Zhang, N. (Author), Zhao, H.-W (Author), Zhao, J. (Author)
Format: Article
Language:English
Published: BioMed Central Ltd 2022
Subjects:
Acute myocardial infarction
Coronavirus disease-2019
First medical contact time
Major adverse cardiac event
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items